LIBERTY 360°: Endovascular interventions improve outcomes across all Rutherford classes - Healio

LIBERTY 360°: Endovascular interventions improve outcomes across all Rutherford classes  Healio

HOLLYWOOD, Fla. — Treatment with FDA-approved endovascular device interventions was associated with improved clinical outcomes at 2.5-year follow-up, ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more